-

SHAREHOLDER ALERT: Robbins LLP Announces that RLX Technology Inc. (RLX) is Being Sued for Misleading Shareholders

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of RLX Technology Inc. (NYSE: RLX) American Depository Shares ("ADS") pursuant or traceable to its January 2021 initial public offering ("IPO"). The complaint asserts claims under the Securities Act of 1933. RLX purports to be the "No. 1 branded e-vapor company in China."

If you suffered a loss due to RLX Technology Inc.'s misconduct, click here.

RLX Technology Inc. (RLX) Made Misstatements Regarding Its Business Prospects

According to the complaint, the Registration Statement contained untrue statements of material fact. Specifically, the Registration Statement omitted RLX's exposure to China's then-existing campaign to establish a national standard for e-cigarettes that would bring them in line with regular cigarette regulations by expressly distancing itself and its products from falling under the administration of China's tobacco monopoly system. The Registration Statement also touted that it expected "to continue to be, benefitting from the rapid growth of China's e-vapor market," while overstating its financial prospects in light of the pending regulations for e-cigarettes.

RLX's shares fell nearly 48% on March 22, 2021, when the Ministry of Industry and Information Technology posted its draft regulations, which confirmed e-cigarettes and new tobacco products would be regulated similar to traditional tobacco offerings. RLX's shares fell again when it published its first quarter 2021 financial results on June 2, 2021, closing at $9.90 per ADS, down 9% from the prior day.

If you purchased shares of RLX Technology Inc. (RLX) pursuant to its January 2021 IPO, you have until August 9, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against RLX Technology Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:RLX

Release Versions
$Cashtags

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

REGENXBIO, Inc. Stockholders Should Contact Robbins LLP for Information About Leading the RGNX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Robbins LLP Informs Investors of the Gemini Space Station, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gemini Space Station, Inc. (NASDAQ: GEMI) Class A common stock pursuant and/or traceable to the Company's September 12, 2025 initial public offering ("IPO"), and/or Gemini Space Station, Inc. securities between September 12, 2025 and February 17, 2026. Gemini was founded to develop and operate a cryptocurrency platform. For more information, s...

uniQure N.V. Stockholders Should Contact Robbins LLP for Information About Leading the QURE Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? September 24, 2025 – October 31, 2025 W...
Back to Newsroom